Mangalam Drugs & Organics Limited is engaged in manufacturing pharma APIs, Intermediates and Specialty Chemicals.
Financial Results:
Mangalam Drugs and Organics Ltd reported Revenues for Q1FY24 of ₹87.46 Crores down from ₹109.49 Crore year on year, a fall of 20.12%.
Total Expenses for Q1FY24 of ₹97.77 Crores down from ₹105.26 Crores year on year, a fall of 7.12%.
Consolidated Net Profit of -₹9.54 Crores from ₹3.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹6.03, from ₹1.90 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.